US-based health technology company Hyperfine has entered a strategic collaboration with computer technology firm NVIDIA to advance AI-powered neuroimaging technology.
The partnership will integrate NVIDIA’s AI expertise and accelerated computing to enhance Hyperfine’s portable magnetic resonance imaging (MRI) system.
It aims to make brain MRI faster and more accessible worldwide and to advance the efficiency and affordability of brain imaging.
Hyperfine will address the challenges linked to brain diseases with its AI-powered portable MR technology, designed for use at the point of care by trained clinicians.
Hyperfine president and CEO Maria Sainz said: “Our mission is to make portable brain imaging faster, more intelligent, and increasingly accessible, ultimately improving health outcomes and reducing costs globally.
“Partnering with NVIDIA presents an incredible opportunity to advance and accelerate our AI technology. I’m thrilled about the possibilities this collaboration brings for the future.”
The collaboration will focus on advancing AI-powered image reconstruction and embedding real-time clinical decision support into the portable MRI workflow.
Hyperfine’s Swoop system will use NVIDIA’s training and inference tools, including DALI and MONAI, to improve image quality, reduce scan times, and enable faster diagnoses.
Swoop is a portable, ultra-low-field magnetic resonance (MR) imaging device that provides images of the head’s internal structure.
The images of internal structure inform the diagnosis when full diagnostic examinations are not clinically recommended.
The portable imaging system was approved by the US Food and Drug Administration (FDA) for brain imaging across all age groups.
Also, Hyperfine received the CE mark in the European Union (EU) and the UKCA mark in the UK, with plans for commercial launch the Swoop system in select international markets.
